EPISODE · Mar 14, 2017 · 12 MIN
March 2017: Better PrEParation needed?
from DTB Podcast · host BMJ Group
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss some of the implications related to funding of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). They consider the Court of Appeal decision on funding and the role of clinical and health economic evaluations for preventative treatments. Full article available here: http://dtb.bmj.com/content/55/3/25. The editors also review the evidence for a new formulation of desmopressin for nocturia in adults (http://dtb.bmj.com/content/55/3/30) and discuss penicillin allergy (http://dtb.bmj.com/content/55/3/33). Find out more about the March issue here: http://dtb.bmj.com/content/55/3/26.
What this episode covers
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss some of the implications related to funding of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). They consider the Court of Appeal decision on funding and the role of clinical and health economic evaluations for preventative treatments. Full article available here: http://dtb.bmj.com/content/55/3/25. The editors also review the evidence for a new formulation of desmopressin for nocturia in adults (http://dtb.bmj.com/content/55/3/30) and discuss penicillin allergy (http://dtb.bmj.com/content/55/3/33). Find out more about the March issue here: http://dtb.bmj.com/content/55/3/26.
NOW PLAYING
March 2017: Better PrEParation needed?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m